MedPath

Daunorubicin Hydrochloride

DAUNORUBICIN HYDROCHLORIDE INJECTION Rx ONLY

Approved
Approval ID

f4312095-3c21-296b-e053-2995a90a0d9c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 1, 2023

Manufacturers
FDA

Hisun Pharmaceuticals USA, Inc.

DUNS: 961628505

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

daunorubicin hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42658-021
Application NumberANDA208759
Product Classification
M
Marketing Category
C73584
G
Generic Name
daunorubicin hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 1, 2023
FDA Product Classification

INGREDIENTS (5)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
DAUNORUBICIN HYDROCHLORIDEActive
Quantity: 5 mg in 1 mL
Code: UD984I04LZ
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Daunorubicin Hydrochloride - FDA Drug Approval Details